編號
C8-024
徵稿主題
Prognosis Survival and Treatment Related Complications
題目
Docetaxel–Cisplatin–Tegafur/Uracil（DCU）合併或未合併免疫治療於可切除頭頸部鱗狀細胞癌的療效與安全性：一項多中心真實世界研究
作者群
湯文誠1,
連銘渝2,
王宏銘1,
方端仁3,
張凱評3,
廖俊達3,
方谷豪3,
黃炳勝4,
林倩伃4,
謝承恩4,
沈奕良4,
李麗玉5,
謝佳訓1
服務單位
1 Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan City
2 Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung
3 Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan
4 Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, Taoyuan City
5 Department of Anatomic Pathology, Linkou Chang Gung Memorial Hospital, Linkou, Taoyuan City
